Abstract: A photopolymerization method in which an ink composition including (A) a polymerizing compound having an ethylenic unsaturated group, (B) a photopolymerization initiator represented by Formula (1) described below, and (C) a hydrogen donor having a structure in which a nitrogen atom is directly bonded to an aromatic ring, in which the aromatic ring has an electron-withdrawing group or the nitrogen atom constitutes a hetero ring, is photopolymerized under acidic conditions, in Formula (1), each of R1 to R30 represents a hydrogen atom, a halogen atom, an alkyl group, or an alkoxy group.
Abstract: According to the present invention, unstable hydrogen of 4,4?,5,5?-tetranitro-2,2?-biimidazole, which is a promising material for insensitive high-performance molecular explosives, may be stabilized by aminoguanidium to provide di(aminoguanidium) 4,4?,5,5?-tetranitro-2,2?-biimidazole, thereby solving the hygroscopicity of 4,4?,5,5?-tetranitro-2,2?-biimidazole, and enhancing performance and insensitivity thereof.
Type:
Grant
Filed:
February 2, 2012
Date of Patent:
April 15, 2014
Assignee:
Agency for Defense Development
Inventors:
Jin Seuk Kim, Seung Hee Kim, Hyoun Soo Kim
Abstract: Small molecule inhibitors of AGBL2 are provided, as well as methods of using the inhibitors to treat or prevent cancer and neurologic disorders.
Type:
Application
Filed:
February 14, 2012
Publication date:
December 12, 2013
Applicant:
GEORGETOWN UNIVERSITY
Inventors:
Stephen W. Byers, Sivanesan Dakshanamurthy, Ziad Sahab
Abstract: The present invention relates to imidazole derivatives and their use as dopants for doping an organic semiconductor matrix material, organic semiconductor materials and electronic or optoelectronic structural elements.
Type:
Grant
Filed:
May 9, 2008
Date of Patent:
June 11, 2013
Assignee:
Novaled AG
Inventors:
Horst Hartmann, Olaf Zeika, Martin Ammann, Rene Dathe
Abstract: An organic electroluminescent device comprising: a pair of electrodes comprising an anode and a cathode, and one or more layers arranged between the anode and the cathode; wherein at least one of the one or more layers is a light emitting layer and wherein the one or more layers, comprises an organic compound represented by a substituted 2,2?-biimidazole.
Type:
Application
Filed:
October 21, 2011
Publication date:
October 18, 2012
Applicant:
Commonwealth Scientific and Industrial Research Organisation
Inventors:
James Matthew MacDonald, Mark Bown, Kazunori Ueno, Karl Peter Weber, Jenny Lee O'Connell, Tadahiko Hirai
Abstract: According to the present invention, unstable hydrogen of 4,4?,5,5?-tetranitro-2,2?-biimidazole, which is a promising material for insensitive high-performance molecular explosives, may be stabilized by aminoguanidium to provide di(aminoguanidium) 4,4?,5,5?-tetranitro-2,2?-biimidazole, thereby solving the hygroscopicity of 4,4?,5,5?-tetranitro-2,2?-biimidazole, and enhancing performance and insensitivity thereof.
Type:
Application
Filed:
February 2, 2012
Publication date:
August 9, 2012
Applicant:
Agency for Defense Development
Inventors:
Jin Seuk Kim, Seung Hee Kim, Hyoun Soo Kim
Abstract: The claimed invention relates to a process for preparing (meth)acrylates of N-hydroxyalkylated amides, in which open-chain N-hydroxyalkylated amides are esterified with (meth)acrylic acid or transesterified with at least one (meth)acrylic ester in the presence of at least one heterogeneous catalyst selected from the group consisting of an inorganic salt and an enzyme.
Abstract: Disclosed are compounds of Formula 1, including all geometric and stereoisomers, N-oxides, and salts thereof, wherein J is Q2 or R1; X is N, CR2 or CQ3; Y is N or CR3; Z is N or CR4; and Q1, Q2, Q3, R1 R2 and R3 are as defined in the disclosure. Also disclosed are compositions containing the compounds of Formula 1 and methods for controlling plant disease caused by a fungal pathogen comprising applying an effective amount of a compound or a composition of the invention.
Type:
Application
Filed:
May 7, 2009
Publication date:
February 24, 2011
Applicant:
E.I. Du Pont De Nemours and Company
Inventors:
Thomas Paul Selby, James Francis Bereznak, John Joseph Bisaha, Amy X. Ding, Mary Ann Hanagan, Jeffrey Keith Long, Andrew Edmund Taggi, Vijayagopal Gopalsamuthiram
Abstract: The present invention relates to imidazole derivatives and their use as dopants for doping an organic semiconductor matrix material, organic semiconductor materials and electronic or optoelectronic structural elements.
Type:
Application
Filed:
May 9, 2008
Publication date:
December 2, 2010
Applicant:
NOVALED AG
Inventors:
Horst Hartmann, Olaf Zeika, Martin Ammann, Rene Dathe
Abstract: Heterocyclic compounds, compositions comprising them, and methods of their use for the treatment, prevention and management of inflammatory and autoimmune diseases and disorders are disclosed.
Type:
Grant
Filed:
August 24, 2009
Date of Patent:
November 2, 2010
Assignee:
Lexicon Pharmaceuticals, Inc.
Inventors:
David J. Augeri, Jeffrey Bagdanoff, Simon D. P. Baugh, Kenneth G. Carson, Theodore C. Jessop, James E. Tarver
Abstract: Heterocyclic compounds, compositions comprising them, and methods of their use for the treatment, prevention and management of inflammatory and autoimmune diseases and disorders are disclosed.
Type:
Grant
Filed:
February 28, 2008
Date of Patent:
October 6, 2009
Assignee:
Lexicon Pharmaceuticals, Inc.
Inventors:
David J. Augeri, Jeffrey Bagdanoff, Simon D. P. Baugh, Kenneth G. Carson, Theodore C. Jessop, James E. Tarver
Abstract: Biimidazole diamide compounds that are useful for binding anions such as sulfate are described, along with the use thereof for purposes such as extracting anions from a waste stream and/or detecting anions.
Abstract: Disclosed is a preparation method of 2,2′-bi-1H-imidazole using glyoxal and an ammonium salt as starting materials through a safe, simple and easily controlled synthetic process with a high yield.
Type:
Grant
Filed:
March 6, 2003
Date of Patent:
March 30, 2004
Assignee:
Agency for Defense Development
Inventors:
Jin Rai Cho, Soo Gyeong Cho, Eun Mee Goh, Jae Kyung Kim
Abstract: The current invention discloses useful pharmaceutical compositions containing amidino derivative useful as nitric oxide synthase inhibitors.
Type:
Grant
Filed:
July 28, 1998
Date of Patent:
September 10, 2002
Assignee:
G.D. Searle & Co.
Inventors:
Donald W. Hansen, Jr., Mark G. Currie, E. Ann Hallinan, Kam F. Fok, Timothy J. Hagen, Arija A. Bergmanis, Steven W. Kramer, Len F. Lee, Suzanne Metz, William M. Moore, Karen B. Peterson, Barnett S. Pitzele, Dale P. Spangler, R. Keith Webber, Mihaly V. Toth, Mahima Trivedi, Foe S. Tjoeng